Summary
Kevin C. Gorman, Ph.D. is the founder and long-serving CEO of Neurocrine Biosciences based in San Diego, bringing a rare combination of scientific rigor and business acumen to biotech leadership. With a PhD in Immunology and an MBA in Finance from UCLA Anderson, he has guided translational neuroscience efforts from research through commercialization since the early 1990s. His tenure reflects deep experience in steering complex drug-development programs, regulatory strategy, and investor relations across the life sciences ecosystem. Known for bridging lab science and capital markets, he pairs technical credibility with an operator’s focus on sustainable growth. Despite a career rooted in academia and industry leadership, he maintains an entrepreneurial mindset that emphasizes translating novel biology into medicines for patients.
8 years of coding experience
Master of Business Administration - MBA, Finance, General, Master of Business Administration - MBA, Finance, General at UCLA Anderson School of Management
Doctor of Philosophy - PhD, Immunology, Doctor of Philosophy - PhD, Immunology at University of California, Los Angeles